mechlorethamine has been researched along with Heart Diseases in 9 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It is suggested that total focal dosage used after chemotherapy be reviewed since total dosage for the entire lymph collector in excess of 30 Gy might contribute to hazards of cardiopathology." | 1.35 | [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]. ( Bozhenko, VK; Datsenko, PV; Ivashin, AV; Mel'nik, IuD; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM, 2009) |
| "Cardiotoxicity is a well recognized side effect of anthracyclines (doxorubicin and epirubicin) or antracenadiones (mitoxantrone) at cumulative or high doses." | 1.29 | Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. ( Arévila, N; Avilés, A; Díaz Maqueo, JC; García, R; Gómez, T; Nambo, MJ, 1993) |
| "Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual." | 1.27 | Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Podol'skiĭ, PN | 1 |
| Datsenko, PV | 1 |
| Pan'shin, GA | 1 |
| Sotnikov, VM | 1 |
| Mel'nik, IuD | 1 |
| Ivashin, AV | 1 |
| Bozhenko, VK | 1 |
| SANSON, J | 1 |
| SLODKI, S | 1 |
| GRUHN, JG | 1 |
| TOURNEUR, R | 1 |
| GRIVAUX, M | 1 |
| LAMOTTE-BARRILLON, S | 1 |
| Diehl, V | 1 |
| Fuchs, M | 1 |
| Harker, WG | 1 |
| Kushlan, P | 1 |
| Rosenberg, SA | 1 |
| Avilés, A | 1 |
| Arévila, N | 1 |
| Díaz Maqueo, JC | 1 |
| Gómez, T | 1 |
| García, R | 1 |
| Nambo, MJ | 1 |
| Allavena, C | 1 |
| Conroy, T | 1 |
| Aletti, P | 1 |
| Bey, P | 1 |
| Lederlin, P | 1 |
| Santoro, A | 1 |
| Bonadonna, G | 1 |
| Valagussa, P | 1 |
| Zucali, R | 1 |
| Viviani, S | 1 |
| Villani, F | 1 |
| Pagnoni, AM | 1 |
| Bonfante, V | 1 |
| Musumeci, R | 1 |
| Crippa, F | 1 |
| Watchie, J | 1 |
| Coleman, CN | 1 |
| Raffin, TA | 1 |
| Cox, RS | 1 |
| Raubitschek, AA | 1 |
| Fahey, T | 1 |
| Hoppe, RT | 1 |
| Van Kessel, A | 1 |
1 review available for mechlorethamine and Heart Diseases
| Article | Year |
|---|---|
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid | 2007 |
1 trial available for mechlorethamine and Heart Diseases
| Article | Year |
|---|---|
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined | 1987 |
7 other studies available for mechlorethamine and Heart Diseases
| Article | Year |
|---|---|
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Heart; | 2009 |
MYOCARDIAL ABSCESSES.
Topics: Abscess; Anti-Bacterial Agents; Aspergillosis; Candidiasis; Clostridium; Electrocardiography; Escher | 1963 |
[DIGESTIVE INTOLERANCE TO DIGITALIN, CYTOSTATIC DRUGS AND VARIOUS THERAPEUTIC DRUGS. THEIR TREATMENT WITH METHOCLOPRAMIDE].
Topics: Antiemetics; Antitubercular Agents; Cobalt Isotopes; Cyclophosphamide; Cytostatic Agents; Digitalis | 1964 |
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1984 |
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up St | 1993 |
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Exerci | 1992 |
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Composition; Elec | 1987 |